Thrombosis Class & MOA Flashcards
Unfractionated Heparin
Indirect Thrombin Inhibitor
Binds antithrombin, potentiating formation of antithrombin-coagulation factor complex (Xa, IIa)
Dalteparin
Indirect Thrombin Inhibitor
LMWH that inhibits thrombin less effectively than Xa
Enoxaparin
Indirect Thrombin Inhibitor
LMWH that inhibits thrombin less effectively than Xa
Tinzaparin
Indirect Thrombin Inhibitor
LMWH that inhibits thrombin less effectively than Xa
Fondaparinux
Indirect Thrombin Inhibitor
Synthetic polysaccharide that binds active site of antithrombin; inhibits Xa.
Warfarin
Vit. K antagonist
Blocks actions of Vit K-dependent gamma carboxylation of Factors II, VII, IX, X, Protein C and S. It does not affect factors already produced.
Lepirudin
Direct Thrombin Inhibitor
Inactivates fibrinogen-bound AND unbound thrombin; irreversible
Bivalirudin
Direct Thrombin Inhibitor
Inactivates fibrinogen-bound AND unbound thrombin; irreversible
Argatroban
Direct Thrombin Inhibitor
Inactivates fibrinogen-bound AND unbound thrombin.
Dabigatran
Direct Thrombin Inhibitor
Inactivates fibrinogen-bound AND unbound thrombin; competitive (reversible!).
Rivaroxaban
Direct Xa Inhibitor
Reversible, binds active site of Xa
Apixaban
Direct Xa Inhibitor
Reversible, binds active site of Xa
Streptokinase
Fibrinolytic
Lyses already formed clots by activating circulating plasminogen (not clot specific).
Urokinase
Fibrinolytic
Lyses already formed clots by activating circulating plasminogen
Reteplase
Fibrinolytic
Lyses already formed clots; more clot specific, less systemic activation
Tenecteplase
Fibrinolytic
Lyses already formed clots; more clot specific, less systemic activation.
Aspirin
Antiplatelet
Irreversibly inhibits platelets, preventing thromboxane A2 formation
Dipyridamole
Antiplatelet
PDE inhibitor –> increase in platelet cAMP
Clopidogrel
Antiplatelet
Inhibits platelet ADP receptors
Abciximab
Antiplatelet
Monoclonal antibody against GPIIb/IIIa
Eptifibatide
Antiplatelet
Fibrinogen Analog which competes with endogenous fibrinogen for IIa/IIIb
Tirofiban
Antiplatelet
Fibrinogen analogs which compete with endogenous fibrinogen and vWF for IIa/IIIb.